Form D · Biotechnology
LumaCyte, Inc.
Charlottesville, VA · CIK 0001589470
Offering snapshot reported Sep 14, 2023 · SEC filing
- Reported sold
- $10M Offering amount: $13M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 21, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 14, 2023 | Initial | $9,999,994 | No comparison | 1 | SEC filing |
| May 17, 2022 | Initial | $525,000 | No comparison | 2 | SEC filing |
| May 17, 2022 | Initial | $1,170,000 | No comparison | 6 | SEC filing |
| May 17, 2022 | Initial | $550,000 | No comparison | 3 | SEC filing |
| May 17, 2022 | Initial | $750,000 | No comparison | 1 | SEC filing |
| May 17, 2022 | Initial | $1,250,000 | No comparison | 2 | SEC filing |
| Mar 2, 2022 | Initial | $6,777,982 | No comparison | 3 | SEC filing |
| May 12, 2014 | Initial | $30,080 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $600K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-492138
Equity to be issued upon conversion of previously issued convertible securities
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| EuroConsult Capital LLC | 143366 |
Source: Form D, filed Sep 14, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Pete Buzy | Director |
| Renee Hart | Director, Executive |
| Sean Hart | Director, Executive |
| Robert Heiser | Director |
| Paul Meister | Director |
| Hart Renee | Executive |
| Dennis Walczewski | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1145 River Road Suite 1
Charlottesville, VA, 22901
Charlottesville, VA, 22901